Journal for ImmunoTherapy of Cancer (Nov 2020)
500 P2RX7 agonist treatment boosts the ability of IL-12-activated CD8+ T cells to infiltrate and control murine melanoma
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)